| Latest | F'cast | |
|---|---|---|
| Div Yield | 4.8% | |
| Div Cover | 1.6 | |
| Op Mrgn | 11.0% | |
| ROCE | 20.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 13.1 | |
| PEG | 0.3 | |
| Pr/Revenue | 1.1 | |
| Pr/Book | 1.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 0.3% | |
| PBT | 35.0% | |
| EPS | 47.4% | |
| DPS | 16.5% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-19 | 99,852.00 | 5,624.00 | 151.00¢ | 16.6 | 0.2 | +91% | 73.00¢ | 2.9% |
| 31-Dec-20 | 93,915.00 | 4,872.00 | 125.00¢ | 15.6 | n/a | -17% | 143.00¢ | 7.3% |
| 31-Dec-21 | 99,931.00 | 9,196.00 | 298.00¢ | 8.8 | 0.1 | +138% | 154.00¢ | 5.9% |
| 31-Dec-22 | 83,384.00 | 6,583.00 | 213.00¢ | 12.2 | n/a | -28% | 170.00¢ | 6.5% |
| 31-Dec-23 | 83,627.00 | 8,886.00 | 314.00¢ | 9.4 | 0.2 | +47% | 198.00¢ | 6.7% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 98,869.05 | 10,216.42 | 390.98¢ | 10.5 | 0.4 | +24% | 231.84¢ | 0.0% |
| 31-Dec-26 | 103,748.96 | 10,245.52 | 414.73¢ | 9.9 | 1.6 | +6% | 248.67¢ | 0.0% |
| 31-Dec-27 | 110,561.48 | 10,970.35 | 443.23¢ | 9.3 | 1.4 | +7% | 267.14¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| 'NORMAL' LIFE BAD FOR RESOLUTION | 19-Apr-2011 | Express & Star |
| £40m Axa deal boosts troubled Rok | 01-Sep-2010 | The Scotsman |
| AXA in rights issue but Asian bid is snubbed | 10-Nov-2009 | The Independent |
| Currency | Euro |
| Share Price | 41.20 |
| Change Today | 0.37 |
| % Change | 0.91 % |
| 52 Week High | 43.40 |
| 52 Week Low | 33.48 |
| Volume | 9,567,892 |
| Shares Issued | 2,232.00m |
| Market Cap | 91,958m |
| Beta | 1.00 |
| Strong Buy | 7 |
| Buy | 7 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 16 |

| Time | Volume / Share Price |
| 17:35 | 926 @ 41.20 |
| 17:35 | 12,164 @ 41.20 |
| 17:35 | 25,811 @ 41.20 |
| 17:35 | 11,901 @ 41.20 |
| 17:35 | 25,634 @ 41.20 |
You are here: research